Alleh Lindquist

In a pioneering study recently published in the journal Pharmaceuticals, researchers have validated the effectiveness and safety of FloraWorks’ TruCBN in improving sleep quality. This study, conducted by Radicle Science, represents a significant milestone in cannabinoid research, marking the...

With another year behind us with no federal legalization of marijuana and no approval of the SAFE Banking Act, the industry’s biggest problem remains the lack of access to capital. What will happen in 2024? Are we any closer to either of these reforms? At first glance it...

U.S. regulators are currently making decisions on behalf of the cannabis industry, such as reclassifying it from a Schedule I to a Schedule III controlled substance. The move certainly bodes well for the overall industry, but there's just one problem, according to Christine De La Rosa of The...

FloraWorks, a cannabinoid therapeutics company specializing in rare and novel cannabinoids, has successfully completed a $2.25 million Series-A financing round. Leading this significant investment was life sciences venture capital firm, Bonaventure Equity LLC. Other participants in the round...

Drippy Enterprises Inc., a cannabis beverage brand in California launched new product line, "Deep End", a 4oz, 100 mg THC drink that's low in sugar and calories. The company has used artificial intelligence to design the packaging for this new drink. Drippy's product lines utilize...